JCJean Content

Jean Content

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jean Content has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • IS1096-mediated DNA rearrangements play a key role in genome evolution of Mycobacterium smegmatis

    by Xiao-Ming Wang, Alexandra Galamba, Digby F. Warner, Karine Soetaert, Jane S. Merkel, Michael Kalai, Pablo Bifani, Philippe Lefèvre, Valerie Mizrahi, Jean Content


  • Open Access

    The Mycobacterium bovis homologous protein of the Mycobacterium tuberculosis serine/threonine protein kinase Mbk (PknD) is truncated

    by Priska Peirs, Benoît Parmentier, Luk De Wit, Jean Content

    We previously identified a 70-kDa serine/threonine protein kinase (MbK or PknD) from Mycobacterium tuberculosis Erdman containing a transmembrane domain and bearing a 270-amino acid N-terminal kinase domain. With the use of a polyclonal serum, Mbk has now been identified by Western blotting in protein extracts from M. tuberculosis and confirmed to be localised in the envelope. An identical mbk gene has been found by sequencing different M. tuberculosis and M. africanum strains. Surprisingly, in two virulent M. bovis strains and four different strains of M. bovis BCG, an additional adenine after position 829 of the open reading frame was found that produces a frame shift resulting in a predicted truncated, presumably free cytoplasmic protein, encoding only the N-terminal 30-kDa Mbk kinase domain. This sequence polymorphism has been confirmed by Western blot analysis of M. bovis BCG protein extracts.


  • Analysis of the Mechanism of Action of Anti‐human Interleukin‐6 and Anti‐human Interleukin‐6 Receptor‐neutralising Monoclonal Antibodies

    by Michael Kalai, Fèlix A. Montero‐Julian, Just P. J. Brakenhoff, Véronique Fontaine, Lucas De Wit, Axel Wollmer, Hervé Brailly, Jean Content, Joachim Grötzinger

    Anti‐human interleukin‐6 (human IL‐6) and anti‐human IL‐6 receptor (IL‐6R)‐neutralising monoclonal antibodies (mAbs) are among the most promising human lL‐6‐specific inhibitors and have been shown to exert short‐term beneficial effects in clinical trials. Simultaneous treatment with different anti‐human IL‐6 or anti‐human IL‐6R mAbs was recently suggested to be a potent way to inhibit the action of the cytokine in vivo. Although some of these mAbs are already used, their mechanisms of action and the location of their epitopes on the surface of human IL‐6 and human IL‐6R are still unknown. Here, we analysed the capacity of several anti‐human IL‐6 and anti‐human IL‐6R mAbs to inhibit the interaction between human IL‐6, human IL‐6R, and human glycoprotein 130 (gp130). We mapped the epitopes of several of these mAbs by studying their binding to human IL‐6 and human IL‐6R mutant proteins. Our results show that several anti‐human IL‐6 and anti‐human IL‐6R‐neutralising mAbs block the binding between human IL‐6 and human IL‐6R, whereas others block the binding to gpl 30. We provide evidence that some of the latter mAbs inhibit interaction with gp130β1, whereas others interfere with the binding to gp130β2. Our results suggest that residues included in the C′D′ loop of human IL‐6R interact with gp130β2.


  • Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG

    by P Lefèvre, M Braibant, L de Wit, M Kalai, D Röeper, J Grötzinger, J P Delville, P Peirs, J Ooms, K Huygen, et al.

    A gene encoding a protein homologous to the periplasmic ABC phosphate binding receptor PstS from Escherichia coli was cloned and sequenced from a lambda gt11 library of Mycobacterium tuberculosis by screening with monoclonal antibody 2A1-2. Its degree of similarity to the E. coli PstS is comparable to those of the previously described M. tuberculosis phosphate binding protein pab (Ag78, Ag5, or 38-kDa protein) and another M. tuberculosis protein which we identified recently. We suggest that the three M. tuberculosis proteins share a similar function and could be named PstS-1, PstS-2, and PstS-3, respectively. Molecular modeling of their three-dimensional structures using the structure of the E. coli PstS as a template and their inducibility by phosphate starvation support this view. Recombinant PstS-2 and PstS-3 were produced and purified by affinity chromatography. With PstS-1, these proteins were used to demonstrate the specificity of three groups of monoclonal antibodies. Using these antibodies in flow cytometry and immunoblotting analyses, we demonstrate that the three genes are expressed and their protein products are present and accessible at the mycobacterial surface as well as in its culture filtrate. Together with the M. tuberculosis genes encoding homologs of the PstA, PstB, and PstC components we cloned before, the present data suggest that at least one, and possibly several, related and functional ABC phosphate transporters exist in mycobacteria. It is hypothesized that the mycobacterial gene duplications presented here may be a subtle adaptation of intracellular pathogens to phosphate starvation in their alternating growth environments.